Stasik, S., Burkhard-Meier, C., Kramer, M., Middeke, J. M., Oelschlaegel, U., Sockel, K., . . . Thiede, C. (2022). Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. Blood advances, 6(11), . https://doi.org/10.1182/bloodadvances.2021006233
Chicago-Zitierstil (17. Ausg.)Stasik, Sebastian, et al. "Deep Sequencing in CD34+ Cells from Peripheral Blood Enables sensitive Detection of Measurable Residual Disease in AML." Blood Advances 6, no. 11 (2022). https://doi.org/10.1182/bloodadvances.2021006233.
MLA-Zitierstil (9. Ausg.)Stasik, Sebastian, et al. "Deep Sequencing in CD34+ Cells from Peripheral Blood Enables sensitive Detection of Measurable Residual Disease in AML." Blood Advances, vol. 6, no. 11, 2022, https://doi.org/10.1182/bloodadvances.2021006233.